Evidence-based Treatment Options in Cannabis Dependency

被引:15
|
作者
Walther, Lisa [1 ]
Gantner, Andreas [2 ]
Heinz, Andreas [1 ,3 ]
Majic, Tomislav [3 ]
机构
[1] Charite, Dept Psychiat & Psychotherapy, Campus Mitte, Berlin, Germany
[2] Therapieladen eV, Berlin, Germany
[3] Charite, St Hedwig Hosp, Dept Psychiat & Psychotherapy, Charite Campus Mitte, Berlin, Germany
来源
DEUTSCHES ARZTEBLATT INTERNATIONAL | 2016年 / 113卷 / 39期
关键词
RANDOMIZED CONTROLLED-TRIAL; MULTIDIMENSIONAL FAMILY-THERAPY; COGNITIVE-BEHAVIORAL THERAPY; PLACEBO-CONTROLLED TRIAL; STUDENT MARIJUANA USE; DOUBLE-BLIND; USE DISORDERS; TREATMENT PROGRAM; MOTIVATIONAL ENHANCEMENT; BRIEF INTERVENTION;
D O I
10.3238/arztebl.2016.0653
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Now that the consumption of natural and synthetic cannabinoids is becoming more widespread, the specific treatment of cannabis-related disturbances is an increasingly important matter. There are many therapeutic options, and it is not always clear which ones are evidence-based and appropriate for use in a given clinical situation. Methods: This review is based on reports of pertinent randomized and controlled trials (RCTs) that were retrieved by a selective search in the PubMed and Cochrane databases. Results: Cognitive behavior therapy (CBT) combined with other techniques has been found to have a moderate to large effect (Cohen's d = 0.53-0.9) on the amount of cannabis consumed as well as on the level of psychosocial functioning or the dependence syndrome. Systemic multidimensional family therapy (MDFT) has been found beneficial for younger adolescents who consume large amounts of cannabis and have psychiatric comorbidities. Short-term interventions with motivational talk therapy have been found effective for patients with or without an initial desire to achieve cannabis abstinence. All of these psychotherapeutic interventions are effective at evidence level Ia. The administration of gabapentin had a weak effect (d = 0.26) on the quantity consumed and on abstinence (evidence level Ib). Withdrawal symptoms can be alleviated with cannabinoid-receptor antagonists (d = 0.223 and 0.481) (evidence level Ib). On the other hand, there is evidence that serotonergic antidepressants can worsen withdrawal manifestations and increase the likelihood of relapse. Conclusion: Psychotherapeutic techniques remain the foundation of treatment for cannabis dependence. No drug has yet been approved for the treatment of cannabis dependence because of the lack of scientific evidence. The rates of abstinence that are currently achieved, even with psychotherapy, are still only moderate. Further clinical studies are needed for the evaluation of combinations of various treatments that can meet the needs of individual patients.
引用
收藏
页码:653 / +
页数:9
相关论文
共 50 条
  • [21] Current treatment options for abnormal uterine bleeding: An evidence-based approach
    Istre, Olav
    Qvigstad, Erik
    BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2007, 21 (06) : 905 - 913
  • [22] Treatment options for IgA nephropathy in adults: a proposal for evidence-based strategy
    Laville, M
    Alamartine, E
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (08) : 1947 - 1951
  • [23] Navigating Antiplatelet Treatment Options for Stroke: Evidence-Based and Pragmatic Strategies
    Moustafa, Bayan
    Testai, Fernando D.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2022, 22 (11) : 789 - 802
  • [24] Idiopathic pulmonary fibrosis: treatment options in pursuit of evidence-based approaches
    Raghu, G.
    EUROPEAN RESPIRATORY JOURNAL, 2006, 28 (03) : 463 - 465
  • [25] Navigating Antiplatelet Treatment Options for Stroke: Evidence-Based and Pragmatic Strategies
    Bayan Moustafa
    Fernando D. Testai
    Current Neurology and Neuroscience Reports, 2022, 22 : 789 - 802
  • [26] Treating onychotillomania can be challenging as no evidence-based treatment options are available
    Adis Medical Writers
    Drugs & Therapy Perspectives, 2018, 34 (5) : 212 - 215
  • [27] Current Evidence-Based Interdisciplinary Treatment Options for Pediatric Musculoskeletal Pain
    Line Caes
    Emma Fisher
    Jacqui Clinch
    Christopher Eccleston
    Current Treatment Options in Rheumatology, 2018, 4 (3) : 223 - 234
  • [28] Development of an evidence-based decision pathway for vestibular schwannoma treatment options
    Linkov, Faina
    Valappil, Benita
    McAfee, Jacob
    Goughnour, Sharon L.
    Hildrew, Douglas M.
    McCall, Andrew A.
    Linkov, Igor
    Hirsch, Barry
    Snyderman, Carl
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2017, 38 (01) : 57 - 64
  • [29] Combined pharmacotherapy and evidence-based psychosocial Cannabis treatment for youth and selection of cannabis-using friends
    Meisel, Samuel N.
    Padovano, Hayley Treloar
    Miranda, Robert, Jr.
    DRUG AND ALCOHOL DEPENDENCE, 2021, 225
  • [30] Cannabis: high time for evidence-based policies
    不详
    LANCET ONCOLOGY, 2017, 18 (01): : 1 - 1